Manufacturing

Review of SUT Adoption in Biopharma Manufacturing

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Automating the Future of Fill/Finish

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

AbbVie Collaborates with BigHat Biosciences on Next-Gen Therapeutic Antibodies

December 08, 2023

This collaboration will combine BigHat Biosciences’ AI/ML-guided Milliner platform with AbbVie's expertise in oncology and neuroscience to develop next-generation antibodies.

MilliporeSigma Launches AI Solution for Integrating Drug Discovery and Molecule Synthesis

December 08, 2023

MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.

Exploring Best Practice Tech Transfer Methods for CGTs

December 06, 2023

Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.

Training for Operational Excellence

December 03, 2023

The bio/pharmaceutical industry is struggling with the challenge of staffing and training.

Risks and Rewards of Investing in RNA-based Genetic Medicine Manufacturing

December 03, 2023

Collaboration is a key component to achieving long-term success with genetic medicines.

Revolutionizing Biomanufacturing: The Digitalization Advantage

December 03, 2023

Digital transformation allows for smarter and connected biomanufacturing operations.

Falling Short

December 02, 2023

Drug shortages across Europe are being exacerbated by increased demand, struggling supply chains, and manufacturer suspensions.

Novo Nordisk to Make Multi-Billion Dollar Investment in Expansion of Production Facilities in France

December 01, 2023

Novo Nordisk will invest more than DKK 16 billion (US$2.3 billion) to expand its production facilities in Chartres, France.

New Medicines, Markets, and Manufacture: CRISPR for Sickle Cell Disease and β-thalassemia

November 30, 2023

Exagamglogene autotemcel seen as synechdoche.

TAU Systems to Establish TAU Labs, a New Laser Plasma Accelerator Application Center

November 29, 2023

TAU Systems plans to establish TAU Labs, a new next-generation, laser-driven plasma accelerator laboratory, in Carlsbad, Calif.